Back to search

University of North Florida. Department of Psychology

Novel Therapy for Nicotine Addiction in Alcohol Dependent Rats

Abstract

dc:description.abstract

The co-dependence of nicotine and alcohol addiction occurs at high rates, complicates treatment, and is often associated with significant morbidity and mortality. Treatment options of alcohol and tobacco co-dependence are limited. Currently, there are drugs available for nicotine dependence or alcohol dependence. However, there are no therapeutic drugs available on the market for the co-dependence of nicotine and alcohol. Therefore, and important opportunity of new therapeutic options and drug development has presented itself. NT69L, a non-selective neurotensin (NT) agonist, provides a potential novel therapy for nicotine addiction in alcoholics by interacting with the common neurotransmitter circuits supporting the rewarding process for both nicotine and alcohol. Considering the behavioral effects of NT69L in attenuating nicotine self-administration in rats and alcohol consumption in mice, the present study was designed to assess the effects of NT69L as a new drug. NT69L was used in the treatment of nicotine addiction in an animal model of alcoholics and in attempts to attenuate withdrawal signs associated with nicotine and alcohol dependence. Wistar rats pre-exposed to alcohol vapor or air were allowed to self-infuse nicotine (0.03mg/kg/infusion) or saline. When the rats reached a stable level of responding, the effect of pretreatment with NT69L (1mg/kg i.p.) on the reinforcing effect of nicotine was determined. Animals self-infused nicotine at a significantly (p < .05) higher rate compared to saline in both air and alcohol vapor exposed groups. Acute pretreatment with a single injection of NT69L significantly (p < .05) reduced nicotine self-infusion in both the alcohol vapor and the air exposed groups for 5 days post-injection. Additionally, NT69L attenuated the alcohol- and nicotine-induced withdrawal signs associated with the discontinuation of alcohol and nicotine administration. Neurotensin agonist, NT69L, may represent a potential novel therapy to treat the co-addiction of alcohol and nicotine.

Degree

thesis:*
Name thesis:degree_name
Master of Arts in General Psychology (MAGP)
Discipline thesis:degree_discipline
Psychology
Grantor dc:publisher
University of North Florida. Department of Psychology
Date dc:date.issued
Summer

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Stennett, Bethany Ann
  • Stennett, Bethany Ann, 1989-
Advisors dc:contributor.advisor
  • Lange, Lori
  • Boules, Mona
Contributors dc:contributor
  • Dr. Lori Lange
  • Dr. Mona Boules

Subjects

dc:subject × 7

Rights

dc:rights

Identifiers

dc:identifier.*
Repository record dc:identifier
https://digitalcommons.unf.edu/etd/465

Chain of custody

source
Harvested from
University of North Florida
Base URL
digitalcommons.unf.edu/do/oai/
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Stennett, Bethany Ann; Stennett, Bethany Ann, 1989-. Novel Therapy for Nicotine Addiction in Alcohol Dependent Rats. University of North Florida. Department of Psychology, https://digitalcommons.unf.edu/etd/465